The Inside the Clinic series is a video series of various experts at John Theurer Cancer Center speaking to a number of approaches in multiple myeloma, non-Hogkin lymphoma, CAR T-cell therapy, and next-generation sequencing.
EP. 1: Inside the Clinic: JTCC Experts Highlight Pivotal Ongoing Trials in Multiple Myeloma
David Siegel, MD, PhD, Noa Biran, MD, and David H. Vesole, MD, PhD, discuss ongoing clinical trials in multiple myeloma.
Watch
EP. 2: Inside the Clinic: JTCC Experts Highlight Key Takeaways from ASH 2021
David Siegel, MD, PhD, Noa Biran, MD, and David H. Vesole, MD, PhD, discuss key takeaways from ASH 2021.
EP. 3: Inside the Clinic: JTCC Experts Highlight Next Steps With CAR T-Cell Therapy
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss next steps with CAR T-cell therapy.
EP. 4: Inside the Clinic: JTCC Experts Discuss Retreatment With CAR T-Cell Therapy
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss retreatment with CAR T-cell therapy.
EP. 5: Inside the Clinic: JTCC Experts Highlight Optimal Strategies for CAR T-Cell–Related AEs
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss optimal strategies for CAR T-cell–related adverse effects.
EP. 6: Inside the Clinic: JTCC Experts Discuss Approaches to CAR T-Cell Therapy
Lori A. Leslie, MD, and Andre H. Goy, MD, discuss approaches to CAR T-cell therapy.
EP. 7: Inside the Clinic: JTCC Experts Share Strategies for When CAR T-Cell Therapy Is Not an Option
Lori A. Leslie, MD, and Andre H. Goy, MD, share strategies for when CAR T-cell therapy is not an option.
EP. 8: Inside the Clinic: Experts Discuss Practical Aspects of Next-Generation Sequencing
Maher Albitar, MD, and Andre H. Goy, MD, discuss practical aspects of next-generation sequencing.
EP. 9: Inside the Clinic: Experts Highlight Molecular Complexities in MCL
Maher Albitar, MD, and Andre H. Goy, MD, share insights regarding molecular complexities in mantle cell lymphoma.
EP. 10: Inside the Clinic: Experts Discuss Testing for Molecular Abnormalities in AML
Maher Albitar, MD, and Andre H. Goy, MD, discuss the importance of testing for molecular abnormalities in acute myeloid leukemia.
EP. 11: Inside the Clinic: Experts Explore Case Studies in DLBCL
Maher Albitar, MD, and Andre H. Goy, MD, discuss case studies in diffuse large B-cell lymphoma.
Observation Is a Reasonable Alternative to Adjuvant PD-1 Blockade in Stage IIB/IIIC Melanoma
Dr Oluwole on CRS and Neurotoxicity Beyond 2 Weeks After Axi-Cel Infusion in R/R LBCL
Dr Garfall on Ide-Cel and Lenalidomide Maintenance in Myeloma After Suboptimal ASCT Response
Piflufolastat F18 Imaging Is Associated With High Clinician Confidence in Prostate Cancer Management
AUTX-703 Receives FDA Fast Track Designation in Relapsed/Refractory AML
FDA Accepts sBLA for Nivolumab/Ipilimumab in Unresectable/Metastatic MSI-H/dMMR CRC
Anna Parks Receives American Society of Hematology Junior Faculty Scholar Award
Building the Next Generation of Oncology PAs